USD 138.44
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 792.62 Billion JPY | 7.97% |
2023 | 734.09 Billion JPY | 9.51% |
2022 | 670.32 Billion JPY | 20.07% |
2021 | 558.26 Billion JPY | -4.16% |
2020 | 582.47 Billion JPY | 1.77% |
2019 | 572.35 Billion JPY | 5.76% |
2018 | 541.17 Billion JPY | 10.5% |
2017 | 489.72 Billion JPY | -4.94% |
2016 | 515.18 Billion JPY | 3.92% |
2015 | 495.73 Billion JPY | 13.99% |
2014 | 434.87 Billion JPY | 5.48% |
2013 | 412.26 Billion JPY | 6.06% |
2012 | 388.69 Billion JPY | -7.37% |
2011 | 419.61 Billion JPY | 1.47% |
2010 | 413.52 Billion JPY | -8.95% |
2009 | 454.19 Billion JPY | -5.7% |
2008 | 481.63 Billion JPY | 23.47% |
2007 | 390.09 Billion JPY | 13.32% |
2006 | 344.22 Billion JPY | 11.7% |
2005 | 308.17 Billion JPY | 13.53% |
2004 | 271.44 Billion JPY | 10.21% |
2003 | 246.29 Billion JPY | 4.69% |
2002 | 235.26 Billion JPY | -0.65% |
2001 | 236.8 Billion JPY | 17.75% |
2000 | 201.11 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 189.6 Billion JPY | -0.23% |
2024 FY | 762.61 Billion JPY | 3.88% |
2024 Q4 | 196.82 Billion JPY | 1.04% |
2024 Q3 | 194.79 Billion JPY | 3.23% |
2024 Q2 | 188.7 Billion JPY | -0.48% |
2023 FY | 734.09 Billion JPY | 9.51% |
2023 Q1 | 181.35 Billion JPY | 4.32% |
2023 Q2 | 186.35 Billion JPY | 2.76% |
2023 Q4 | 190.04 Billion JPY | 7.76% |
2023 Q3 | 176.35 Billion JPY | -5.36% |
2022 Q1 | 158.94 Billion JPY | 3.81% |
2022 FY | 670.32 Billion JPY | 20.07% |
2022 Q4 | 173.84 Billion JPY | 0.79% |
2022 Q3 | 172.48 Billion JPY | 4.5% |
2022 Q2 | 165.05 Billion JPY | 3.84% |
2021 Q1 | 113.72 Billion JPY | -16.72% |
2021 Q4 | 153.11 Billion JPY | 2.26% |
2021 Q2 | 141.69 Billion JPY | 24.59% |
2021 Q3 | 149.73 Billion JPY | 5.67% |
2021 FY | 558.26 Billion JPY | -4.16% |
2020 Q2 | 155.34 Billion JPY | 9.1% |
2020 Q3 | 148.16 Billion JPY | -4.62% |
2020 FY | 582.47 Billion JPY | 1.77% |
2020 Q1 | 142.39 Billion JPY | -0.83% |
2020 Q4 | 136.55 Billion JPY | -7.83% |
2019 Q3 | 145.1 Billion JPY | 0.91% |
2019 Q4 | 143.58 Billion JPY | -1.05% |
2019 Q2 | 143.79 Billion JPY | 2.8% |
2019 Q1 | 139.87 Billion JPY | 2.04% |
2019 FY | 572.35 Billion JPY | 5.76% |
2018 Q1 | 128.31 Billion JPY | 0.61% |
2018 FY | 541.17 Billion JPY | 10.5% |
2018 Q4 | 137.08 Billion JPY | -1.64% |
2018 Q3 | 139.36 Billion JPY | 2.16% |
2018 Q2 | 136.41 Billion JPY | 6.32% |
2017 Q1 | 116.3 Billion JPY | -6.26% |
2017 Q4 | 127.53 Billion JPY | 2.76% |
2017 Q3 | 124.1 Billion JPY | 1.9% |
2017 Q2 | 121.78 Billion JPY | 4.71% |
2017 FY | 489.72 Billion JPY | -4.94% |
2016 FY | 515.18 Billion JPY | 3.92% |
2016 Q2 | 134.96 Billion JPY | 6.17% |
2016 Q1 | 127.12 Billion JPY | -2.09% |
2016 Q4 | 124.06 Billion JPY | -3.85% |
2016 Q3 | 129.03 Billion JPY | -4.39% |
2015 FY | 495.73 Billion JPY | 13.99% |
2015 Q4 | 129.83 Billion JPY | 0.33% |
2015 Q3 | 129.4 Billion JPY | 5.88% |
2015 Q2 | 122.22 Billion JPY | 6.96% |
2015 Q1 | 114.27 Billion JPY | -2.25% |
2014 Q1 | 101.89 Billion JPY | -8.77% |
2014 FY | 434.87 Billion JPY | 5.48% |
2014 Q2 | 103.49 Billion JPY | 1.58% |
2014 Q3 | 112.68 Billion JPY | 8.87% |
2014 Q4 | 116.9 Billion JPY | 3.75% |
2013 Q4 | 111.68 Billion JPY | 19.26% |
2013 Q3 | 93.64 Billion JPY | -10.8% |
2013 Q1 | 106.74 Billion JPY | 15.57% |
2013 FY | 412.26 Billion JPY | 6.06% |
2013 Q2 | 104.98 Billion JPY | -1.64% |
2012 Q1 | 106.02 Billion JPY | 2.88% |
2012 Q2 | 104.98 Billion JPY | -0.97% |
2012 Q3 | 85.94 Billion JPY | -18.14% |
2012 FY | 388.69 Billion JPY | -7.37% |
2012 Q4 | 92.36 Billion JPY | 7.47% |
2011 Q4 | 103.05 Billion JPY | -4.98% |
2011 Q1 | 105.59 Billion JPY | 0.72% |
2011 Q2 | 107.07 Billion JPY | 1.4% |
2011 Q3 | 108.44 Billion JPY | 1.28% |
2011 FY | 419.61 Billion JPY | 1.47% |
2010 Q3 | 106.87 Billion JPY | 0.06% |
2010 Q4 | 104.83 Billion JPY | -1.91% |
2010 Q2 | 106.81 Billion JPY | 12.45% |
2010 Q1 | 94.98 Billion JPY | 14.55% |
2010 FY | 413.52 Billion JPY | -8.95% |
2009 Q1 | 130.15 Billion JPY | -4.17% |
2009 Q3 | 112.74 Billion JPY | -12.18% |
2009 Q4 | 82.92 Billion JPY | -26.44% |
2009 FY | 454.19 Billion JPY | -5.7% |
2009 Q2 | 128.37 Billion JPY | -1.37% |
2008 FY | 481.63 Billion JPY | 23.47% |
2008 Q4 | 135.81 Billion JPY | -7.64% |
2008 Q3 | 147.05 Billion JPY | 45.63% |
2008 Q2 | 100.98 Billion JPY | 3.27% |
2008 Q1 | 97.77 Billion JPY | 0.0% |
2007 FY | 390.09 Billion JPY | 13.32% |
2006 FY | 344.22 Billion JPY | 11.7% |
2005 FY | 308.17 Billion JPY | 13.53% |
2004 FY | 271.44 Billion JPY | 10.21% |
2003 FY | 246.29 Billion JPY | 4.69% |
2002 FY | 235.26 Billion JPY | -0.65% |
2001 FY | 236.8 Billion JPY | 17.75% |
2000 FY | 201.11 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | -24835696.876% |
Ansell Limited | 1.61 Billion USD | -48848.805% |
Ansell Limited | 1.61 Billion USD | -48848.805% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | -429165.532% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -586892647.399% |
Psykey, Inc. | 419.29 Thousand USD | -189036363.24% |
ConvaTec Group Plc | 2.19 Billion USD | -36026.816% |
ConvaTec Group Plc | 2.14 Billion USD | -36897.199% |
Encision Inc. | 6.58 Million USD | -12035159.666% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | -43433356.169% |
LifePoint, Inc. | -18.5 Thousand USD | 4284475775.676% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -11633952.547% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | -102671920.725% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | -80370202.772% |
Reflect Scientific, Inc. | 1.08 Million USD | -73380917.892% |
SmileDirectClub, Inc. | 470.74 Million USD | -168278.075% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -42250.085% |
SheerVision, Inc. | 3.49 Million USD | -22650251.902% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | -57175939.137% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | -106379640.516% |
Yubo International Biotech Limited | 104.28 Thousand USD | -760073929.324% |